Article
Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease.
Clinical chemistry - 1 Jan 2006
Kerkeni Mohsen, Addad Faouzi, Chauffert Maryline, Myara Anne, Ben Farhat Mohamed, Miled Abdelhedi, Maaroufi Khira, Trivin François
Abstract excerpt
BACKGROUND: Hyperhomocysteinemia is an independent, graded risk factor for coronary artery disease (CAD). The G894T variant of endothelial nitric oxide synthase (eNOS) was postulated to be associated with hyperhomocysteinemia and could influence individual susceptibility to CAD. The aims of this study were to investigate (a) the relationship of the eNOS G894T polymorphism with the presence and the severity of CAD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
